Search Ontology:
ChEBI
(S)-(-)-sulpiride
- Term ID
- CHEBI:64119
- Synonyms
-
- (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- (-)-sulpiride
- (S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- (S)-sulpiride
- levosulpirida
- levosulpiride
- levosulpiridum
- N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
- S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide
- Definition
- An optically active form of sulpiride having (S)-configuration. The active enantiomer of the racemic drug sulpiride. Selective D2-like dopamine antagonist (Ki values are ~ 0.015. ~ 0.013, 1, ~ 45 and ~ 77 μM at D2, D3, D4, D1 and D5 receptors respectively).
- References
-
- cas:23672-07-3
- drugbank:DB00391
- drugcentral:1577
- kegg.drug:D07312
- lincs.smallmolecule:LSM-5624
- patent:KR20110090142
- patent:US2011052700
- pubmed:18186115
- pubmed:19165957
- pubmed:19452563
- pubmed:19488984
- pubmed:19795476
- pubmed:20438811
- pubmed:20656570
- pubmed:20850200
- pubmed:21223496
- pubmed:21615988
- reaxys:3563418
- wikipedia.en:Levosulpiride
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from (S)-(-)-sulpiride
Phenotype where environments contain (S)-(-)-sulpiride
Phenotype modified by environments containing (S)-(-)-sulpiride
Phenotype affecting (S)-(-)-sulpiride
Human Disease Model